A detailed history of Voisard Asset Management Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 630 shares of LLY stock, worth $475,650. This represents 0.23% of its overall portfolio holdings.

Number of Shares
630
Previous 666 5.41%
Holding current value
$475,650
Previous $603 Million 7.41%
% of portfolio
0.23%
Previous 0.29%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$772.14 - $960.02 $27,797 - $34,560
-36 Reduced 5.41%
630 $558 Million
Q2 2024

Jul 15, 2024

BUY
$724.87 - $909.04 $22,470 - $28,180
31 Added 4.88%
666 $603 Million
Q4 2023

Feb 20, 2024

BUY
$525.19 - $619.13 $333,495 - $393,147
635 New
635 $370 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Voisard Asset Management Group, Inc. Portfolio

Follow Voisard Asset Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voisard Asset Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voisard Asset Management Group, Inc. with notifications on news.